meRfi®-GM
The Digital Textbook on Gut Microbiota and Beyond
Gastrointestinal Diseases
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Antibiotic therapy often destroys the natural gut microbiota, promoting the infection and proliferation of antibiotic-resistant enteric pathogens
Many gastrointestinal pathologies, including chemotherapy-induced intestinal toxicity and Inflammatory Bowel Disease (IBD), exhibit an increase in regulated cell death (e.g., apoptosis) during disease.
…
References (Sources)
- .01 The continuing importance of bile acids in liver and intestinal disease
- Apoptosis of crypt epithelial cells in ulcerative colitis
- Chemotherapy-driven dysbiosis in the intestinal microbiome.
- Potential of gut-derived short-chain fatty acids to control enteric pathogens
- Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial
- The gut microbiota shapes intestinal immune responses during health and disease.